- Home
- CC vs OCUL Comparison
CC vs OCUL Comparison
Compare CC & OCUL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CC
- OCUL
- Stock Information
- Founded
- CC 2014
- OCUL 2006
- Country
- CC United States
- OCUL United States
- Employees
- CC N/A
- OCUL N/A
- Industry
- CC Major Chemicals
- OCUL Biotechnology: Pharmaceutical Preparations
- Sector
- CC Industrials
- OCUL Health Care
- Exchange
- CC Nasdaq
- OCUL Nasdaq
- Market Cap
- CC 1.6B
- OCUL 1.4B
- IPO Year
- CC N/A
- OCUL 2014
- Fundamental
- Price
- CC $10.74
- OCUL $8.13
- Analyst Decision
- CC Buy
- OCUL Strong Buy
- Analyst Count
- CC 9
- OCUL 10
- Target Price
- CC $17.67
- OCUL $16.11
- AVG Volume (30 Days)
- CC 3.9M
- OCUL 2.5M
- Earning Date
- CC 07-31-2025
- OCUL 08-06-2025
- Dividend Yield
- CC 7.77%
- OCUL N/A
- EPS Growth
- CC N/A
- OCUL N/A
- EPS
- CC 0.18
- OCUL N/A
- Revenue
- CC $5,788,000,000.00
- OCUL $59,647,000.00
- Revenue This Year
- CC $4.91
- OCUL N/A
- Revenue Next Year
- CC $3.82
- OCUL $20.05
- P/E Ratio
- CC $59.73
- OCUL N/A
- Revenue Growth
- CC N/A
- OCUL N/A
- 52 Week Low
- CC $9.13
- OCUL $5.79
- 52 Week High
- CC $25.54
- OCUL $11.78
- Technical
- Relative Strength Index (RSI)
- CC 46.57
- OCUL 48.84
- Support Level
- CC $10.44
- OCUL $8.44
- Resistance Level
- CC $11.74
- OCUL $9.41
- Average True Range (ATR)
- CC 0.62
- OCUL 0.47
- MACD
- CC 0.06
- OCUL -0.06
- Stochastic Oscillator
- CC 55.15
- OCUL 17.42
About CC Chemours Company (The)
The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.
About OCUL Ocular Therapeutix Inc.
Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Its pipeline product includes Dextenza, OTX-TIC, OTX-TKI, and OTX-IVT.